Where does Shionogi & Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Shionogi & Co., Ltd. ranks #2,084 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Shionogi & Co., Ltd. hold?

Shionogi & Co., Ltd. holds 190 US utility patents granted between 2015 and 2025, spanning 20 technology areas.

What is Shionogi & Co., Ltd.'s Innovation Score?

Shionogi & Co., Ltd. has an Innovation Score of 47.6 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Shionogi & Co., Ltd.'s patent grant rate increasing or decreasing?

Shionogi & Co., Ltd.'s recent grant velocity is -59% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Shionogi & Co., Ltd.'s patents?

Shionogi & Co., Ltd.'s patents average 15.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Shionogi & Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Shionogi & Co., Ltd.

Q: What technology areas does Shionogi & Co., Ltd. focus on?

Shionogi & Co., Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 171 patents. Grants appear in 20 CPC subclasses total.

USPTO PatentsView assignee record - 190 granted patents across 20 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Shionogi ranks #2,084 of 49,997 tracked US assignees by granted-patent volume, with 190 patents across 20 technology areas.

#2,084
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.6/100): 15.7
avg claims per patent: -59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2084 · Foreign Corporation #2,084 · 190 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 190 grants
TOP-DECILE #2,084/49,997
PHOTO-FINISH National Central…
CPC-FOCUS A61P · 20 areas
INNOV-PAR 47.6/100
CLAIMS-RICH 15.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -59% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Central University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Belenos Clean Power… · near

48
Bracco Suisse · near

48
NeuroWave Systems · near

48
Shionogi & · this assignee

48
Switch · near

48
3D Lighting… · lowest

7

What this shows Shionogi's Innovation Score is 47.6/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Shionogi's grants concentrate

Shionogi & Co., Ltd. is a focused PatentsView assignee: 20 CPC subclasses with 90% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (35 grants) versus a trough of 9 in 2023. By volume, Shionogi sits between National Central University and Chiesi Farmaceutici S.p.A..

Shionogi's three-year grant acceleration

From 2019–2021 to 2022–2024, Shionogi & Co., Ltd. moved from 44 to 28 grants (0.64x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,344. See the growth leaderboard.

National Central…

190
Ocado Innovation

190
Richwave Technolo…

190
Rigel Pharmaceuti…

190
Smith & Nephew Or…

190
Volvo Lastvagnar…

190
Shionogi & ◀

190
Allscripts Softwa…

189
Chiesi Farmaceuti…

189

What this shows Shionogi holds 190 patents at rank #2,084, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Shionogi

By rank, the assignees closest to #2,084 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Shionogi's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Shionogi, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (48 here).

Switch, Ltd. 48 Belenos Clean Power Holding AG 48 Bracco Suisse SA 48 NeuroWave Systems Inc. 48

Similar claim depth

Nearest assignees by average claims per patent (15.7 here).

Kone Corporation 15.7 avg International Business Machines Corporation 15.7 avg Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) 15.7 avg Rockwell Automation Asia Pacific Business Center Pte. Ltd. 15.7 avg

Shionogi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Shionogi & Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	35	18.4%
2016	30	15.8%
2017	23	12.1%
2018	23	12.1%
2019	19	10.0%
2020	14	7.4%
2021	11	5.8%
2022	10	5.3%
2023	9	4.7%
2024	9	4.7%
2025partial year	7	3.7%

Which technologies does Shionogi & Co., Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 171

C07D - Heterocyclic Compounds 139

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 125

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 24

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 24

C07C - Acyclic OR Carbocyclic Compounds 20

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 15

C07K - Peptides 14

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 6

Y02A - Technologies FOR Adaptation TO Climate Change 6

C12Y - Enzymes 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

Top 15 of 20 technology areas

Where it ranks

Overall rank by patents

#2,084

of 49,997 tracked assignees

Innovation Score

47.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Shionogi & Co., Ltd.'s patent record in context - here's where to go next.

Shionogi & Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #2,084 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Shionogi & Co., Ltd. against National Central University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.